Topsoe Holding A/S - 26 Jun 2023 Form 4 Insider Report for IGM Biosciences, Inc. (IGMS)

Role
10%+ Owner
Signature
/s/ Misbah Tahir, by power of attorney
Issuer symbol
IGMS
Transactions as of
26 Jun 2023
Net transactions value
+$13,500,000
Form type
4
Filing time
28 Jun 2023, 19:35:25 UTC
Previous filing
05 Apr 2022
Next filing
14 Aug 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IGMS Non-Voting Common Stock Purchase $13,500,000 +1,687,500 +50% $8.00 5,044,295 26 Jun 2023 Common Stock 1,687,500 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Non-Voting Common Stock is convertible into the Issuer's Common Stock on a 1-for-1 basis (subject to a 4.99% beneficial ownership limitation that may be increased or decreased by the Reporting Person) and has no expiration date.
F2 The shares were purchased pursuant to an underwritten public offering of the Issuer's securities.
F3 The shares are held directly by Topsoe Holding A/S. Jakob Haldor Topsoe, Christina Teng Topsoe, Anne Haugwitz-Hardenberg-Reventlow, Emil Oigaard, Thomas Schleicher and Birgitte Nielsen, members of the board of directors of Topsoe Holding A/S, may be deemed to share voting and investment power with respect to the shares reported herein and disclaim beneficial ownership of such shares, except to the extent of his or her pecuniary interest therein, if any. Jakob Haldor Topsoe and Christina Teng Topsoe are members of the Issuer's board of directors.